Opportunity Information: Apply for RFA AG 24 045
The National Institutes of Health (NIH) funding opportunity titled "Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)" (Funding Opportunity Number: RFA-AG-24-045) supports human subject research aimed at explaining why older adults respond so differently to the same exercise training programs. The central theme is response variability: some people show meaningful gains in physical function and physiology with training, while others improve only modestly or in different ways. This NOFO is looking for rigorous clinical trials that move beyond showing that exercise works on average and instead dig into the biological, behavioral, and environmental reasons outcomes vary from person to person in later life.
The NOFO specifically encourages projects that identify systemic modulators and measurable indicators of response differences, such as biomarkers and other plausible mechanisms that could explain who benefits, how, and under what conditions. The endpoints of interest should be clinically relevant for older adults, meaning outcomes tied to health and independence rather than purely laboratory measures. While the announcement does not list specific endpoints in the excerpt provided, the intent clearly points toward measures that reflect real-world function and physiology in aging, such as mobility, strength, endurance, cardiometabolic function, and other markers that could translate into improved quality of life, reduced disability, or better resilience.
A major emphasis is on transdisciplinary, mechanism-oriented work that combines innovative study designs and advanced analytic approaches with deep clinical phenotyping. In practice, that means NIH is signaling interest in studies that capture detailed participant characteristics (phenotypes) and use modern methods to untangle complex cause-and-effect relationships. The NOFO highlights the interplay of endogenous and exogenous factors driving variation in exercise response. Endogenous factors generally include internal characteristics such as genetics, underlying physiology, inflammatory or metabolic status, comorbidities, medication use, and baseline functional capacity. Exogenous factors generally include external influences such as diet, sleep, psychosocial stress, neighborhood and built environment, access to resources, prior physical activity exposure, and adherence supports. The goal is not only to map these influences, but also to determine which factors are modifiable so they can be targeted to make exercise prescriptions more precise and more effective for older adults.
The long-term payoff NIH is aiming for is practical: if researchers can clarify why responses vary and identify actionable drivers of that variability, clinicians and public health practitioners could tailor exercise prescriptions with greater precision. Instead of a one-size-fits-all training plan, the field could move toward matching the type, intensity, volume, and progression of exercise to an individual older adult's biology, circumstances, and risks, improving the likelihood of meaningful benefits while reducing trial-and-error and potentially avoiding adverse responses.
This opportunity uses the NIH R01 grant mechanism and explicitly requires a clinical trial, meaning applicants are expected to prospectively assign human participants to an intervention (in this case, exercise training and potentially comparative conditions) and evaluate health-related outcomes. The funding instrument type is a grant, and the activity category is health. The CFDA number listed is 93.866, which is associated with NIH aging-related programs. The award ceiling is $1,000,000, indicating the maximum award amount expected under this announcement. The original closing date provided is 2023-11-03, and the opportunity was created on 2023-08-09.
Eligibility is broad and includes many types of organizations: state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those categories); for-profit organizations other than small businesses; small businesses; and other entities. The NOFO also explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility aligns with the real-world nature of exercise research in older populations, where community settings, diverse participant recruitment, and multidisciplinary partnerships often matter as much as laboratory capacity.
In short, this NIH NOFO is focused on clinical trials in older adults that explain heterogeneity in exercise training outcomes by identifying systemic modulators, biomarkers, and mechanisms, and by using innovative, transdisciplinary approaches to model how internal biology and external context interact. The intended impact is to enable more individualized and clinically effective exercise prescriptions that better support healthy aging and functional independence.Apply for RFA AG 24 045
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-08-09.
- Applicants must submit their applications by 2023-11-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: F24AS00060 Protecting and Conserving African Elephant Priority Populations
Previous opportunity: NOI: Enhancing the Electric Power Systems’ Reliability and Resilience via Sensor Data Analytics Demonstrations
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 24 045
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 24 045) also looked into and applied for these:
| Funding Opportunity |
|---|
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) Apply for PAR 23 250 Funding Number: PAR 23 250 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) Apply for PAR 23 249 Funding Number: PAR 23 249 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed) Apply for RFA NS 24 006 Funding Number: RFA NS 24 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed) Apply for RFA AG 24 028 Funding Number: RFA AG 24 028 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed) Apply for RFA AG 24 029 Funding Number: RFA AG 24 029 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed) Apply for RFA NS 24 007 Funding Number: RFA NS 24 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 24 041 Funding Number: RFA AG 24 041 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 24 042 Funding Number: RFA AG 24 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) Apply for PAR 24 029 Funding Number: PAR 24 029 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity Apply for 72065623APS00001 Funding Number: 72065623APS00001 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $92,000,000 |
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) Apply for PAR 23 258 Funding Number: PAR 23 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 24 043 Funding Number: RFA AG 24 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 24 027 Funding Number: RFA NS 24 027 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030 Funding Number: RFA NS 23 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290 Funding Number: PA 23 290 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291 Funding Number: PA 23 291 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 274 Funding Number: PAR 23 274 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046 Funding Number: RFA AG 24 046 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162 Funding Number: RFA MH 24 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027 Funding Number: RFA AG 24 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 24 045", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
